Atlas Trials

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

Clinical trial NCT02597439 · COMPLETED

Trial details

NCT number
NCT02597439
Sponsor
Rene Kahn
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ultra High Risk for Psychosis
Start date
2016-09-30
Primary completion
2023-02-01
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.